High-field MRS in clinical drug development

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.7, 2013-08, pp. : 849-863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical pharmacology in drug development — an update

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 243-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Unique Potential for Noninvasive Imaging in Modernizing Drug Development and in Transforming Therapeutics: PET/MRI/MRS

By Wolf Walter

Pharmaceutical Research, Vol. 28, Iss. 3, 2011-03 ,pp. : 490-493

Springer Publishing Company

Access to resources Recommend Favorite

Issues for Clinical Drug Development in Neurodegenerative Diseases

By Dib Michel

Drugs, Vol. 65, Iss. 17, 2005-01 ,pp. : 2463-2479

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

By Yang Bing-Bing Lum Peggy Chen Alin Arends Rosalin Roskos Lorin Smith Brian Ruixo Juan José Pérez

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 729-740

Adis International

Access to resources Recommend Favorite

Current pharmacogenomic approaches to clinical drug development

By Murphy Michael P

Pharmacogenomics, Vol. 1, Iss. 2, 2000-05 ,pp. : 115-123

Future Medicine

Access to resources Recommend Favorite